NCT03090373

Brief Summary

This is a double blinded rct to evaluate the effect of the UroShield SAW transducer on preventing bacterial colonization in longterm indwelling catheters. The duration of the trial is 30 days. The investigator will be quantifying the number of bacterial colonies in the urinary catheter and in the bladder in both the treatment and control group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 20, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 24, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2018

Completed
Last Updated

March 24, 2017

Status Verified

March 1, 2017

Enrollment Period

12 months

First QC Date

March 20, 2017

Last Update Submit

March 23, 2017

Conditions

Keywords

CatheterUTI's

Outcome Measures

Primary Outcomes (1)

  • Bacterial Colonization

    Number of cultured colonies from both the Urinary Catheter and retained urine

    30 days

Study Arms (2)

Control Group

SHAM COMPARATOR

At catheter replacement subjects will have a sham UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization.

Device: UroShield

Treatment Group

ACTIVE COMPARATOR

At catheter replacement subjects will have an active UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization.

Device: UroShield

Interventions

UroShieldDEVICE

The UroShield is an externally applied acoustic actuator which generates surface acoustic waves and transmits them along the length of the catheter. The device does not come in direct contact with the subjects.

Also known as: Surface Acoustic Wave Actuator
Control GroupTreatment Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently being treated with an indwelling urinary catheter for at least 30 days.
  • Ability to sign informed consent or have someone authorized to sign informed consent.

You may not qualify if:

  • Currently being treated for an active Urinary Tract infection.
  • Previous treatment with Surface Acoustic Waves.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NanoVibronix

Elmsford, New York, 07055, United States

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Masking Details
The UroShield device actuator will activate and create the hum, which is the only sign of its working even in the active device. While the active device will transmit Surface Acoustic Waves, the sham device will work but will not transmit any acoustic waves.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a double blinded, randomized controlled trial. All involved will be blinded as to whether the supplied UroShield device is active or a sham.
Sponsor Type
INDIV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2017

First Posted

March 24, 2017

Study Start

January 1, 2017

Primary Completion

December 31, 2017

Study Completion

March 1, 2018

Last Updated

March 24, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Data will NOT be shared beyond the investigators of this study.

Locations